[Rubella in pregnant women in Abidjan (Ivory Coast)]. 1987

S A Ouattara, and J P Brettes, and Y Aron, and V Akran, and M Meite, and I Sanogo, and R Kodjo

1,143 serums samples collected from pregnant females at first term were tested for the presence of rubella haemagglutination inhibition antibodies. Rubella antibodies were present in 679 (59.4%) of the pregnant females and 464 (40.6%) were seronegative. No statistically significant difference was found in the prevalence of rubella specific antibodies in three age categories considered. 155 positive serum samples for rubella antibodies (IHA) were tested afterward retrospectively for rubella-specific IgM by ELISA technic, and 14 (9.03%) were positive.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D005260 Female Females
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

S A Ouattara, and J P Brettes, and Y Aron, and V Akran, and M Meite, and I Sanogo, and R Kodjo
August 1999, Contraception,
S A Ouattara, and J P Brettes, and Y Aron, and V Akran, and M Meite, and I Sanogo, and R Kodjo
July 1965, Clinical pediatrics,
S A Ouattara, and J P Brettes, and Y Aron, and V Akran, and M Meite, and I Sanogo, and R Kodjo
July 2003, Vaccine,
S A Ouattara, and J P Brettes, and Y Aron, and V Akran, and M Meite, and I Sanogo, and R Kodjo
January 1993, Bulletin de la Societe de pathologie exotique (1990),
S A Ouattara, and J P Brettes, and Y Aron, and V Akran, and M Meite, and I Sanogo, and R Kodjo
January 1998, Sante (Montrouge, France),
S A Ouattara, and J P Brettes, and Y Aron, and V Akran, and M Meite, and I Sanogo, and R Kodjo
January 2014, Sante publique (Vandoeuvre-les-Nancy, France),
S A Ouattara, and J P Brettes, and Y Aron, and V Akran, and M Meite, and I Sanogo, and R Kodjo
January 1991, Bulletin de la Societe de pathologie exotique (1990),
S A Ouattara, and J P Brettes, and Y Aron, and V Akran, and M Meite, and I Sanogo, and R Kodjo
August 1989, Lancet (London, England),
S A Ouattara, and J P Brettes, and Y Aron, and V Akran, and M Meite, and I Sanogo, and R Kodjo
January 2002, Revue de laryngologie - otologie - rhinologie,
S A Ouattara, and J P Brettes, and Y Aron, and V Akran, and M Meite, and I Sanogo, and R Kodjo
September 2014, Medecine et maladies infectieuses,
Copied contents to your clipboard!